All Stories

  1. DNA Binding, DNA Photocleavage, Molecular Docking Studies and Photo-Induced Effect on Melanoma Cells of 2-Methyl-3-OR Quinazolinone Derivatives
  2. Synthesis and Biological Evaluation of Novel Mixed-Ligand 99mTc-Labeled Anthraquinone Complexes as Potential DNA-Targeted Imaging Agents
  3. Cobalt(II) Complexes of 4′-Bromo-Fenamic Acid: Antioxidant Properties, Antibacterial Activity, and Interaction with DNA and Albumins
  4. Manganese(II) Complexes with 3,5–Dibromosalicylaldehyde: Characterization and Interaction Studies with DNA and Albumins
  5. Synthesis, Characterization and Biological Profile of Cationic Cobalt Complexes with First-Generation Quinolones
  6. Cobalt(II) Complexes of 4′–Nitro–Fenamic Acid: Characterization and Biological Evaluation
  7. Iron(III) Complexes with Substituted Salicylaldehydes: Synthesis, Interaction with DNA and Serum Albumins, and Antioxidant Activity
  8. A mononuclear zinc(ii) complex and a tetranuclear copper(ii) azametallacoronate with (E)-2-((2-(quinazolin-4-yl)hydrazono)methyl)phenol: structure and biological activity
  9. Copper(ii) complexes with (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline and non-steroidal anti-inflammatory drugs: structure and biological evaluation
  10. Manganese(II) Complexes with Non-Steroidal Anti-Inflammatory Drugs: Structure and Biological Activity
  11. Amine-substituted heterocyclic thioamide Cu(I) and Ag(I) complexes as effective anticancer and antibacterial agents targeting the periplasm of E. coli bacteria
  12. Novel Tricarbonylrhenium-Anthrapyrazole Complexes with DNA-Binding and Antitumor Properties: In Vitro and In Vivo Pharmacokinetic Studies with 99mTc-Analogue
  13. One-Pot, Multi-Component Green Microwave-Assisted Synthesis of Bridgehead Bicyclo[4.4.0]boron Heterocycles and DNA Affinity Studies
  14. Erbium(III) complexes with fluoroquinolones: Structure and biological properties
  15. Coordination Compounds of Nickel(II) with 3,5–Dibromo–Salicylaldehyde: Structure and Interaction with Biomolecules
  16. Copper(II) complexes with non-steroidal anti-inflammatory drugs and neocuproine: Structure and biological evaluation
  17. Cu(ii) complexes with a salicylaldehyde derivative and α-diimines as co-ligands: synthesis, characterization, biological activity. Experimental and theoretical approach
  18. Coordination compounds of cobalt(ii) with carboxylate non-steroidal anti-inflammatory drugs: structure and biological profile
  19. Neutral and cationic nickel(II) complexes with substituted salicylaldehydes: Characterization, antibacterial activity, and interaction with biomacromolecules
  20. Transition metal(II) complexes with the non–steroidal anti–inflammatory drug oxaprozin: Characterization and biological profile
  21. Erbium(III) coordination compounds with substituted salicylaldehydes: Characterization and biological profile
  22. pH-Sensitive Gold Nanorods for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Delivery and DNA-Binding Studies
  23. Iron(III) Complexes with Non-Steroidal Anti-Inflammatory Drugs: Structure, Antioxidant and Anticholinergic Activity, and Interaction with Biomolecules
  24. Metal Complexes with Naphthalene-Based Acetic Acids as Ligands: Structure and Biological Activity
  25. Effect of Arylazo Sulfones on DNA: Binding, Cleavage, Photocleavage, Molecular Docking Studies and Interaction with A375 Melanoma and Non-Cancer Cells
  26. Copper(II) complexes with 3,5–dihalogeno–salicylaldehydes: Synthesis, structure and interaction with DNA and albumins
  27. Inhibition of Cancer Cell Proliferation and Bacterial Growth by Silver(I) Complexes Bearing a CH3-Substituted Thiadiazole-Based Thioamide
  28. Copper(II) Complexes of 5–Fluoro–Salicylaldehyde: Synthesis, Characterization, Antioxidant Properties, Interaction with DNA and Serum Albumins
  29. Copper(II) complexes with 4-(diethylamino)salicylaldehyde and α-diimines: Anticancer, antioxidant, antigenotoxic effects and interaction with DNA and albumins
  30. Manganese(II) complexes with 5–nitro–2–hydroxy–benzaldehyde or substituted 2–hydroxy–phenones: Structure and interaction with bovine serum albumin and calf–thymus DNA
  31. Palladium(II) Complexes of Substituted Salicylaldehydes: Synthesis, Characterization and Investigation of Their Biological Profile
  32. In silico study of potential antiviral activity of copper(II) complexes with non–steroidal anti–inflammatory drugs on various SARS–CoV–2 target proteins
  33. Metal(II) Complexes of the Fluoroquinolone Fleroxacin: Synthesis, Characterization and Biological Profile
  34. Structure and in vitro and in silico biological activity of zinc(II) complexes with 3,5–dichloro–salicylaldehyde
  35. In vitro biological activity of copper(II) complexes with NSAIDs and nicotinamide: Characterization, DNA- and BSA-interaction study and anticancer activity
  36. Biocompatible silver(I) complexes with heterocyclic thioamide ligands for selective killing of cancer cells and high antimicrobial activity – A combined in vitro and in silico study
  37. Manganese(II) complexes of substituted salicylaldehydes and α-diimines: Synthesis, characterization and biological activity
  38. Zinc(II) complexes of 3,5–dibromo–salicylaldehyde and α–diimines: Synthesis, characterization and in vitro and in silico biological profile
  39. Stimuli-responsive spin crossover nanoparticles for drug delivery and DNA-binding studies
  40. Zinc(ii) complexes of 3-bromo-5-chloro-salicylaldehyde: characterization and biological activity
  41. Transition metal(ii) complexes of halogenated derivatives of (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline: structure, antioxidant activity, DNA-binding DNA photocleavage, interaction with albumin andin silicostudies
  42. Silver(i) complexes bearing heterocyclic thioamide ligands with NH2 and CF3 substituents: effect of ligand group substitution on antibacterial and anticancer properties
  43. Copper(II) complexes with non–steroidal anti–inflammatory drugs: Structural characterization, in vitro and in silico biological profile
  44. Synthesis, characterization and (in vitro and in silico) biological activity of a series of dioxouranium(VI) complexes with non-steroidal anti-inflammatory drugs
  45. Nickel(II)–meclofenamate complexes: Structure, in vitro and in silico DNA– and albumin–binding studies, antioxidant and anticholinergic activity
  46. Structure and biological profile of transition metal complexes with (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline
  47. Trinuclear and tetranuclear iron(III) complexes with fenamates: Structure and biological profile
  48. Copper(II) complexes with meclofenamate ligands: Structure, interaction with DNA and albumins, antioxidant and anticholinergic activity
  49. Interaction of manganese(II) with the hybrid molecule (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline: Structure and biological profile
  50. Synthesis, structural determination, in vitro and in silico biological evaluation of divalent or trivalent cobalt complexes with indomethacin
  51. Facile Method to Prepare pH-Sensitive PEI-Functionalized Carbon Nanotubes as Rationally Designed Vehicles for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Delivery
  52. Zn(II) complexes of (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline in combination with non-steroidal anti-inflammatory drug sodium diclofenac: Structure, DNA binding and photo-cleavage studies, antioxidant activity and interaction with albumin
  53. Silver complexes with heterocyclic thioamide and tertiary arylphosphane ligands: Synthesis, crystal structures, in vitro and in silico antibacterial and cytotoxic activity, and interaction with DNA
  54. Structure and biological evaluation of pyridine-2-carboxamidine copper(II) complex resulting from N′-(4-nitrophenylsulfonyloxy)2-pyridine-carboxamidoxime
  55. Copper(II) and zinc(II) coordination compounds of non-steroidal anti-inflammatory drugs: Structural features and antioxidant activity
  56. Transition metal complexes with a novel guanine-based (E)-2-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazolin-4(3H)-one: Synthesis, characterization, interaction with DNA and albumins and antioxidant activity
  57. p-Pyridinyl oxime carbamates: synthesis, DNA binding, DNA photocleaving activity and theoretical photodegradation studies
  58. Manganese(II) coordination compounds of carboxylate non-steroidal anti-inflammatory drugs
  59. Novel copper(ii) complexes with fenamates and isonicotinamide: structure and properties, and interactions with DNA and serum albumin
  60. A palladium(II) complex with the Schiff base 4-chloro-2-(N-ethyliminomethyl)-phenol: Synthesis, structural characterization, and in vitro and in silico biological activity studies
  61. Bi- and trinuclear copper(I) compounds of 2,2,5,5-tetramethyl-imidazolidine-4-thione and 1,2-bis(diphenylphosphano)ethane: Synthesis, crystal structures, in vitro and in silico study of antibacterial activity and interaction with DNA and albumins
  62. Cobalt(II) complexes with the non-steroidal anti-inflammatory drug diclofenac and nitrogen-donor ligands
  63. Synthesis, characterization and biological activity of Zn coordination compounds with the quinolone gatifloxacin
  64. Zinc-oxaprozin compounds: Synthesis, structure and biological activity
  65. Homoleptic and heteroleptic silver(I) complexes bearing diphosphane and thioamide ligands: Synthesis, structures, DNA interactions and antibacterial activity studies
  66. Organometallic rhenium tricarbonyl–enrofloxacin and –levofloxacin complexes: synthesis, albumin-binding, DNA-interaction and cell viability studies
  67. Palladium(II) complexes with salicylaldehyde ligands: Synthesis, characterization, structure, in vitro and in silico study of the interaction with calf-thymus DNA and albumins
  68. Manganese coordination compounds of mefenamic acid: In vitro screening and in silico prediction of biological activity
  69. Manganese(II) complexes of tolfenamic acid or naproxen in polymeric structures or encapsulated in [15-MC-5] manganese(III) metallacrowns: Structure and biological activity
  70. Copper(II) diclofenac complexes: Synthesis, structural studies and interaction with albumins and calf-thymus DNA
  71. In vitro and in silico study of the biological activity of manganese(III) inverse-[9-MC-3]-metallacrowns and manganese(II) complexes with the anti-inflammatory drugs diclofenac or indomethacin
  72. Heterocyclic thioamide/phosphine mixed-ligand silver(I) complexes: Synthesis, molecular structures, DNA-binding properties and antibacterial activity
  73. Manganese(II) complexes of the quinolone family member flumequine: Structure, antimicrobial activity and affinity for albumins and calf-thymus DNA
  74. A step-ladder manganese(iii) metallacrown hosting mefenamic acid and a manganese(ii)–mefanamato complex: synthesis, characterization and cytotoxic activity
  75. Ruthenium–arene complexes with NSAIDs: synthesis, characterization and bioactivity
  76. Extending the family of quinolone antibacterials to new copper derivatives: self-assembly, structural and topological features, catalytic and biological activity
  77. Manganese(ii) complexes with the non-steroidal anti-inflammatory drugs naproxen and mefenamic acid: synthesis, structure, antioxidant capacity, and interaction with albumins and DNA
  78. Nickel(II)-indomethacin mixed-ligand complexes: Synthesis, characterization, antioxidant activity and interaction with DNA and albumins
  79. Interaction of zinc(II) with the non-steroidal anti-inflammatory drug niflumic acid
  80. Toward Multifunctional Materials Incorporating Stepladder Manganese(III) Inverse-[9-MC-3]-Metallacrowns and Anti-Inflammatory Drugs
  81. Zinc complexes of diflunisal: Synthesis, characterization, structure, antioxidant activity, and in vitro and in silico study of the interaction with DNA and albumins
  82. Synthesis, structural, thermal characterization and interaction with calf-thymus DNA and albumins of cationic Ni(II) complexes with 2,2′-dipyridylamine and salicylaldehydes
  83. Nickel(ii)–naproxen mixed-ligand complexes: synthesis, structure, antioxidant activity and interaction with albumins and calf-thymus DNA
  84. Copper(I) halide complexes of 2,2,5,5-tetramethyl-imidazolidine-4-thione: Synthesis, structures, luminescence, thermal stability and interaction with DNA
  85. Copper(II) complexes with gatifloxacin
  86. Zinc complexes of flufenamic acid: Characterization and biological evaluation
  87. Ni(II) complexes with 2,2-dipyridylamine and salicylaldehydes: Synthesis, crystal structure and interaction with calf-thymus DNA and albumins
  88. Nickel(II) complexes of flufenamic acid: Characterization, structure and interaction with DNA and albumins
  89. Nickel(II) complexes of the non-steroidal anti-inflammatory drug tolfenamic acid: Synthesis, structure, antioxidant activity and interaction with albumins and calf-thymus DNA
  90. Cobalt(II) complexes of sparfloxacin
  91. Nickel-diflunisal complexes: synthesis, characterization, in vitro antioxidant activity and interaction with DNA and albumins
  92. Characterization and biological properties of copper(II)-ketoprofen complexes
  93. Dinuclear copper(I) complexes of N-methylbenzothiazole-2-thione: synthesis, structures, antibacterial activity and DNA interaction
  94. Co-NSAIDs
  95. Synthesis, characterization and biological evaluation of 99m Tc/Re–tricarbonyl quinolone complexes
  96. Pyridine and p-Nitrophenyl Oxime Esters with Possible Photochemotherapeutic Activity: Synthesis, DNA Photocleavage and DNA Binding Studies
  97. Alkyl and aryl sulfonyl p-pyridine ethanone oximes are efficient DNA photo-cleavage agents
  98. Cd - 5-Cl-saloH
  99. Cd - 5-Br-saloH
  100. Evaluation of O-alkyl and aryl sulfonyl aromatic and heteroaromatic amidoximes as novel potent DNA photo-cleavers
  101. Structure and biological activities of metal complexes of flumequine
  102. New copper(ii) complexes of the anti-inflammatory drug mefenamic acid: a concerted study including synthesis, physicochemical characterization and their biological evaluation
  103. On the Complexity of Dynamic Mechanism Design
  104. Copper(II) Inverse-[9-Metallacrown-3] Compounds Accommodating ­Nitrato or Diclofenac Ligands: Structure, Magnetism, and Biological Activity
  105. Cd - 5-nitro-saloH
  106. Mn-diclofenac complexes
  107. Copper-tolfenamato complexes
  108. Mn3-diclofenac
  109. Ni - mefanamato complexes
  110. Manganese(II)–sparfloxacinato complexes
  111. Cobalt-oxolinato complexes
  112. Cu - saloH
  113. Copper(II)–indomethacin complexes
  114. Thermal analysis and structural characterization of copper(II) complexes with salicyladehydes
  115. Cobalt(II) complexes of enrofloxacin
  116. Synthesis, thermal analysis, and spectroscopic and structural characterizations of tetranuclear nickel(II) cubane-type clusters with 2-hydroxybenzaldehydes or 2-hydroxyphenones
  117. Synthesis, characterization, thermal and DNA-binding properties of new zinc complexes with 2-hydroxyphenones
  118. Zinc-tolfenamato
  119. Manganese(II) complexes of tolfenamic acid
  120. Zinc complexes of mefenamic acid
  121. Zn saloH
  122. Nickel complexes of diclofenac
  123. New Uses for Old Drugs: Attempts to Convert Quinolone Antibacterials into Potential Anticancer Agents Containing Ruthenium
  124. Copper(II) complexes of flufenamic acid
  125. Manganese(II) complexes of niflumic acid
  126. Zinc complexes of oxolinic acid, flumequine, enrofloxacin
  127. Manganese(II) complexes of oxolinic acid and enrofloxacin
  128. Metal complexes of quinolones or NSAIDs: Perspective
  129. Zinc complexes of flumequine
  130. Copper complexes with ofloxacin and norfloxacin - synthesis, structure na bioactivity
  131. Copper(II) complexes of flumequine
  132. A [24-MC-6] Zinc Metallacoronate with a Nonsteroidal Antiinflammatory Drug as the Constructing Ligand
  133. First Palladium(II) and Platinum(II) Complexes from Employment of 2,6-Diacetylpyridine Dioxime: Synthesis, Structural and Spectroscopic Characterization, and Biological Evaluation
  134. Cobalt(II)-tolfenamato complexes
  135. Cobalt - naproxen
  136. Zinc complexes of tolfenamic acid
  137. Copper - diflunisal
  138. Nickel–quinolones-bipyam complexes
  139. Copper(II) complexes of naproxen / diclofenac
  140. Copper(ii) complexes of mefenamic acid
  141. Zinc complexes of sparfoxacin - levofloxacin
  142. Nickel complexes of enrofloxacin
  143. Nickel complexes of flumequine
  144. Metal - sparfloxacin complexes
  145. Zinc(II) complexes of enrofloxacin
  146. Nickel complexes of oxolinic acid
  147. Cobalt(ii) complexes of mefenamic acid
  148. Nickel complexes of sparfloxacin
  149. Structure and DNA-binding properties of bis(quinolonato)bis(pyridine)zinc(II) complexes
  150. Structure, cyclic voltammetry and DNA-binding properties of the bis(pyridine)bis(sparfloxacinato)nickel(II) complex
  151. Characterization and DNA-interaction studies of 1,1-dicyano-2,2-ethylene dithiolate Ni(II) mixed-ligand complexes with 2-amino-5-methyl thiazole, 2-amino-2-thiazoline and imidazole. Crystal structure of [Ni(i-MNT)(2a-5mt)2]
  152. Zinc-oxolinato complexes
  153. Mononuclear metal complexes with ciprofloxacin: Synthesis, characterization and DNA-binding properties
  154. Magnesium complexes of ciprofloxacin
  155. Structure, antimicrobial activity and DNA-binding properties of the cobalt(II)–sparfloxacin complex
  156. Mononuclear metal complexes of the second-generation quinolone antibacterial agent enrofloxacin: Synthesis, structure, antibacterial activity and interaction with DNA
  157. Copper(II) complexes with sparfloxacin and nitrogen-donor heterocyclic ligands: Structure–activity relationship
  158. Novel Copper(II) Complex ofN-Propyl-norfloxacin and 1,10-Phenanthroline with Enhanced Antileukemic and DNA Nuclease Activities
  159. Synthesis, characterization and DNA-binding of the mononuclear dioxouranium(VI) complex with ciprofloxacin
  160. Mononuclear dioxomolybdenum(VI) complexes with the quinolones enrofloxacin and sparfloxacin: Synthesis, structure, antibacterial activity and interaction with DNA
  161. Mononuclear copper(II) complexes with quinolones and nitrogen-donor heterocyclic ligands: Synthesis, characterization, biological activity and interaction with DNA
  162. Neutral mononuclear dioxomolybdenum(VI) and dioxouranium(VI) complexes of oxolinic acid: Characterization and biological evaluation
  163. Synthesis, characterization and interaction with DNA of mononuclear metal complexes with oxolinic acid
  164. Metal complexes with the quinolone antibacterial agent N-propyl-norfloxacin: Synthesis, structure and bioactivity
  165. Synthesis, characterization, antibacterial activity, and interaction with DNA of the vanadyl-enrofloxacin complex
  166. Metal-pipemidato complexes
  167. Structure and biological properties of the copper(II) complex with the quinolone antibacterial drug N-propyl-norfloxacin and 2,2′-bipyridine
  168. Synthesis, structure and biological activity of copper(II) complexes with oxolinic acid
  169. Copper-enrofloxacin complexes
  170. Cu(II) - sparfloxacin
  171. Metal-piroxicam complexes
  172. An Unprecedented Trinuclear Structure Involving Two High-Spin and One Spin-Crossover Iron(II) Centers
  173. Host-Guest Interaction of 12-MC-4, 15-MC-5, and Fused 12-MC-4 Metallacrowns with Mononuclear and Binuclear Carboxylato Complexes: Structure and Magnetic Behavior
  174. Preparation of Site-Differentiated Mixed Ligand and Mixed Ligand/Mixed Metal Metallacrowns
  175. Copper(II) complexes with phenoxyalkanoic acids and nitrogen donor heterocyclic ligands: structure and bioactivity
  176. Structurally Diverse Copper(II)−Carboxylato Complexes:  Neutral and Ionic Mononuclear Structures and a Novel Binuclear Structure
  177. Ni metallacrowns hosting a carboxylic herbicide
  178. CuII-herbicide complexes: structure and bioactivity
  179. Structurally diverse copper(II) herbicide complexes: mono- and bi-nuclear neutral or cationic complexes
  180. Mn(II) - MCPA